The goal of this proposal is to define the overlapping functions of Hox genes in kidney development. The Hox genes encode transcription factors that often serve important roles in the genetic hierarchy of development. During the previous funding period we showed that 26 Hox genes are expressed during kidney development, with Hox genes flanking each other on a single cluster often showing strongly overlapping expression patterns. In addition, through a series of coding sequence exchange gene targeting experiments we showed that flanking Hox proteins are closely related functionally. These observations lead us to the hypothesis that flanking Hox genes, as well as paralogs, have a high level of redundancy during kidney development. To test this hypothesis we propose the creation of a series of mutant mice carrying strings of frameshift mutations in flanking Hox genes. We have devised a novel variant of recombineering that allows the rapid construction of BAG targeting vectors with multiple Hox mutations. A total of eleven targeting experiments will produce mice with overlapping sets of mutations in 17 Hox genes on three clusters. Interbreedings will make mice with compound arrays of flanking and paralogous Hox frameshift mutations. The resulting phenotypes will be analyzed by a combination of histology, immunohistochemistry, in situ hybridizations, and laser capture microdissection-microarray. This study would represent the first genetic dissection of the functional redundancy of both flanking and paralogous Hox genes in kidney development. Our hypothesis predicts synergistic severity of phenotype as additional flanking Hox genes are removed. In addition, the fine expression analysis of the resulting phenotypes, using laser capture and microarrays, will be capable of detecting even subtle shifts in gene expression patterns, defining overlapping sets of Hox target genes and effector pathways.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project (R01)
Project #
5R01DK061916-08
Application #
7582354
Study Section
Urologic and Kidney Development and Genitourinary Diseases Study Section (UKGD)
Program Officer
Hoshizaki, Deborah K
Project Start
2002-04-01
Project End
2011-03-31
Budget Start
2009-04-01
Budget End
2011-03-31
Support Year
8
Fiscal Year
2009
Total Cost
$292,610
Indirect Cost
Name
Cincinnati Children's Hospital Medical Center
Department
Type
DUNS #
071284913
City
Cincinnati
State
OH
Country
United States
Zip Code
45229
Raines, Anna M; Adam, Mike; Magella, Bliss et al. (2013) Recombineering-based dissection of flanking and paralogous Hox gene functions in mouse reproductive tracts. Development 140:2942-52
Brunskill, Eric W; Lai, Hsiao L; Jamison, D Curtis et al. (2011) Microarrays and RNA-Seq identify molecular mechanisms driving the end of nephron production. BMC Dev Biol 11:15
Adam, Mike; Murali, Bhuvana; Glenn, Nicole O et al. (2008) Epigenetic inheritance based evolution of antibiotic resistance in bacteria. BMC Evol Biol 8:52
Hartman, Heather A; Lai, Hsiao L; Patterson, Larry T (2007) Cessation of renal morphogenesis in mice. Dev Biol 310:379-87
Schwab, Kristopher R; Patterson, Larry T; Hartman, Heather A et al. (2007) Pygo1 and Pygo2 roles in Wnt signaling in mammalian kidney development. BMC Biol 5:15
Potter, S Steven; Hartman, Heather A; Kwan, Kin M et al. (2007) Laser capture-microarray analysis of Lim1 mutant kidney development. Genesis 45:432-9
Schwab, Kristopher; Hartman, Heather A; Liang, Hung-Chi et al. (2006) Comprehensive microarray analysis of Hoxa11/Hoxd11 mutant kidney development. Dev Biol 293:540-54
Brunskill, Eric W; Ehrman, Lisa A; Williams, Michael T et al. (2005) Abnormal neurodevelopment, neurosignaling and behaviour in Npas3-deficient mice. Eur J Neurosci 22:1265-76
Patterson, Larry T; Potter, S Steven (2004) Atlas of Hox gene expression in the developing kidney. Dev Dyn 229:771-9
Devarajan, Prasad; Mishra, Jaya; Supavekin, Suroj et al. (2003) Gene expression in early ischemic renal injury: clues towards pathogenesis, biomarker discovery, and novel therapeutics. Mol Genet Metab 80:365-76

Showing the most recent 10 out of 11 publications